Hepatologist: Scott Cotler, MD | Loyola Medicine

COVID-19 (Coronavirus) Update

Loyola Medicine is resuming select health care services. Learn more about resumption of services.

Scott Cotler, MD

Scott Cotler, MD

Medicine

Hepatology
Professor
FCO Division Director, Hepatology

Languages Spoken

English
Patient Ratings
4.9 / 5 (138 Ratings)
<

Clinical Expertise

  • Cirrhosis
  • Hepatitis B And C
  • Hepatocellular Carcinoma
  • Liver Cancer

About Dr. Cotler

Interests

Medical Education

Medical School
University of Chicago Pritzker School of Medicine
Residency
University of Chicago Medical Center - Internal Medicine: General
Fellowship
  • Rush-Presbyterian-St. Luke's Medical Center - Internal Medicine: Gastroenterology
  • University of Washington Medical Center - Internal Medicine: Hepatology

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine Subspecialty Gastroenterology
Transplant Hepatology, American Board of Internal Medicine Subspecialty

Research

  • Gender disparities in liver transplant candidates with nonalcoholic steatohepatitis. Loy, VM; Joyce, C; Bello, S; VonRoenn, N; Cotler, SJ, Clinical transplantation
  • Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival. Wang, F; Bank, T; Malnassy, G; Arteaga, M; Shang, N; Dalheim, A; Ding, X; Cotler, SJ; Denning, MF; Nishimura, MI; Breslin, P; Qiu, W, Hepatology communications
  • Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users. Major, M; Gutfraind, A; Shekhtman, L; Cui, Q; Kachko, A; Cotler, SJ; Hajarizadeh, B; Sacks-Davis, R; Page, K; Boodram, B; Dahari, H, Science translational medicine
View All ResearchShow Less
  • Studies on the Tissue Localization of HKDC1 a Putative Novel Fifth Hexokinase, in Humans, Khan, M. W.; Ding, X.; Cotler, S. J.; Clarke, M.; Layden, B. T., The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
  • Adverse Effect of Post-Discharge Care Fragmentation on Outcomes after Readmissions after Liver Transplantation Kothari, A. N.; Loy, V. M.; Brownlee, S. A.; Ezure, Y.; Schaidle-Blackburn, C.; Cotler, S. J.; di Sabato, D.; Kuo, P. C.; Lu, A. D., Journal of the American College of Surgeons
  • Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth) Parrinello, C. M.; Rudolph, B. J.; Lazo, M.; Gallo, L. C.; Thyagarajan, B.; Cotler, S. J.; Qi, Q.; Seeherunvong, T.; Vidot, D. C.; Strickler, H. D.; Kaplan, R. C.; Isasi, C. R., Journal of clinical gastroenterology
  • Case Series of 10 Patients with Cirrhosis Undergoing Emergent Repair of Ruptured Umbilical Hernias: Natural History and Predictors of Outcomes. Malespin, M; Moore, CM; Fialho, A; de Melo, SW; Benyashvili, T; Kothari, AN; di Sabato, D; Kallwitz, ER; Cotler, SJ; Lu, AD, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
  • Early Hospital Readmissions and Mortality in Patients With Decompensated Cirrhosis Enrolled in a Large National Health Insurance Administrative Database Scaglione, S. J.; Metcalfe, L.; Kliethermes, S.; Vasilyev, I.; Tsang, R.; Caines, A.; Mumtaz, S.; Goyal, V.; Khalid, A.; Shoham, D.; Markossian, T.; Luke, A.; Underwood, H.; Cotler, S. J., Journal of clinical gastroenterology
  • End of treatment RNA-positive/sustained viral response in an individual with acute hepatitis C virus infection treated with direct-acting antivirals Shteyer, E.; Dahari, H.; Gafanovich, I.; Dery, I.; Wolf, D.; Cotler, S. J.; Lurie, Y., Therapeutic advances in gastroenterology
  • Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites. Venepalli, NK; Modayil, MV; Berg, SA; Nair, TD; Parepally, M; Rajaram, P; Gaba, RC; Bui, JT; Huang, Y; Cotler, SJ, WORLD JOURNAL OF HEPATOLOGY
  • Genome-wide association study of iron traits and relation to diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL): potential genomic intersection of iron and glucose regulation? Raffield, L. M.; Louie, T.; Sofer, T.; Jain, D.; Ipp, E.; Taylor, K. D.; Papanicolaou, G. J.; Aviles-Santa, L.; Lange, L. A.; Laurie, C. C.; Conomos, M. P.; Thornton, T. A.; Chen, Y. I.; Qi, Q.; Cotler, S.; Thyagarajan, B.; Schneiderman, N.; Rotter, J. I.; Reiner, A. P.; Lin, H. J., Human molecular genetics
  • HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients Canini, L.; Imamura, M.; Kawakami, Y.; Uprichard, S. L.; Cotler, S. J.; Dahari, H.; Chayama, K., PLoS ONE
  • Modeling HCV cure after an ultra-short duration of therapy with direct acting agents Goyal, A.; Lurie, Y.; Meissner, E. G.; Major, M.; Sansone, N.; Uprichard, S. L.; Cotler, S. J.; Dahari, H., Antiviral Research
  • Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection Canini, L.; Koh, C.; Cotler, S. J.; Uprichard, S. L.; Winters, M. A.; Han, M. A. T.; Kleiner, D. E.; Idilman, R.; Yurdaydin, C.; Glenn, J. S.; Heller, T.; Dahari, H., Hepatology communications
  • Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies Malespin, M.; Benyashvili, T.; Uprichard, S. L.; Perelson, A. S.; Dahari, H.; Cotler, S. J., Therapeutic advances in gastroenterology
  • An assessment of racial differences in the upper limits of normal ALT levels in children and the effect of obesity on elevated values Kliethermes, S.; Ma, M.; Purtell, C.; Balasubramanian, N.; Gonzalez, B.; Layden, T. J.; Cotler, S. J., Pediatric obesity
  • Cure prevents more than transmission of HCV Dahari, H.; Cotler, S. J.; Feld, J. J., Hepatology (Baltimore, Md.)
  • FAK kinase activity is required for the progression of c-Met/beta-catenin-driven HCC Breslin, P.; Kuo, P.; Ding, X.; Cotler, S.; Nishimura, M.; Zhang, J.; Qiu, W.; Arteaga, M.; Zaidi, A.; Shang, N., Gene expression
  • HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir simeprevir or ledipasvir, Dahari, H.; Canini, L.; Graw, F.; Uprichard, S. L.; Araujo, E. S.; Penaranda, G.; Coquet, E.; Chiche, L.; Riso, A.; Renou, C.; Bourliere, M.; Cotler, S. J.; Halfon, P., Journal of Hepatology
  • Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago Dam, L.; Cheng, A.; Tran, P.; Wong, S. S.; Hershow, R.; Cotler, S.; Cotler, S. J., Canadian journal of gastroenterology & hepatology
  • Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago Dam, L.; Cheng, A.; Tran, P.; Wong, S. S.; Hershow, R.; Cotler, S.; Cotler, S. J., Canadian journal of gastroenterology & hepatology
  • Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report Hasin, Y.; Shteingart, S.; Dahari, H.; Gafanovich, I.; Floru, S.; Braun, M.; Shlomai, A.; Verstandig, A.; Dery, I.; Uprichard, S. L.; Cotler, S. J.; Lurie, Y., WORLD JOURNAL OF HEPATOLOGY
  • Inhibition of SIRT2 suppresses hepatic fibrosis Arteaga, M.; Shang, N.; Ding, X.; Yong, S.; Cotler, S. J.; Denning, M. F.; Shimamura, T.; Breslin, P.; Luscher, B.; Qiu, W., American journal of physiology.Gastrointestinal and liver physiology
  • Personality Coping, and Well-Being for People Living with Chronic Hepatitis C., Cellar, DF; Voster, D; Fetters, R; Twitchell, E; Harper, GW; Scott, C, Psychological reports
  • Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C. Duarte-Rojo, A; Fischer, SE; Adeyi, O; Zita, D; Deneke, MG; Selzner, N; Chen, L; Malespin, M; Cotler, SJ; McGilvray, ID; Feld, JJ, Journal of viral hepatitis
  • Resurrection of response-guided therapy for sofosbuvir combination therapies Dahari, H.; Halfon, P.; Cotler, S. J., Journal of Hepatology
  • Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer Kataria, Y.; Deaton, R. J.; Enk, E.; Jin, M.; Petrauskaite, M.; Dong, L.; Goldenberg, J. R.; Cotler, S. J.; Jensen, D. M.; van Breemen, R. B.; Gann, P. H., BMC GASTROENTEROLOGY
  • The time and cost investment required to obtain and initiate direct-acting antiviral therapy Loy, V.; Benyashvili, T.; Adams, W.; Pavkov, D.; O'Mahoney, M.; Cotler, S. J., ANTIVIRAL THERAPY
  • FAK is required for c-Met/beta-catenin-driven hepatocarcinogenesis Shang, N.; Arteaga, M.; Zaidi, A.; Stauffer, J.; Cotler, S. J.; Zeleznik-Le, N. J.; Zhang, J.; Qiu, W., Hepatology (Baltimore, Md.)
  • Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago Echevarria, D.; Gutfraind, A.; Boodram, B.; Major, M.; Del Valle, S.; Cotler, S. J.; Dahari, H., PLoS ONE
  • Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised double-blind, placebo-controlled phase 2A trial, Koh, C.; Canini, L.; Dahari, H.; Zhao, X.; Uprichard, S. L.; Haynes-Williams, V.; Winters, M. A.; Subramanya, G.; Cooper, S. L.; Pinto, P.; Wolff, E. F.; Bishop, R.; Ai Thanda Han, M.; Cotler, S. J.; Kleiner, D. E.; Keskin, O.; Idilman, R.; Yurdaydin, C.; Glenn, J. S.; Heller, T., The Lancet.Infectious diseases
  • Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children Malespin, M.; Sleesman, B.; Lau, A.; Wong, S. S.; Cotler, S. J., Journal of clinical gastroenterology
  • Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage Kallwitz, E. R.; Daviglus, M. L.; Allison, M. A.; Emory, K. T.; Zhao, L.; Kuniholm, M. H.; Chen, J.; Gouskova, N.; Pirzada, A.; Talavera, G. A.; Youngblood, M. E.; Cotler, S. J., Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Reply: To PMID 25098971. Guedj, J; Canini, L; Cotler, S; Dahari, H, Hepatology (Baltimore, Md.)
  • Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy. Canini, L; DebRoy, S; Mari?o, Z; Conway, JM; Crespo, G; Navasa, M; D'Amato, M; Ferenci, P; Cotler, SJ; Forns, X; Perelson, AS; Dahari, H, ANTIVIRAL THERAPY
  • Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics Dahari, H.; Shteingart, S.; Gafanovich, I.; Cotler, S. J.; D'Amato, M.; Pohl, R. T.; Weiss, G.; Ashkenazi, Y. J.; Tichler, T.; Goldin, E.; Lurie, Y., Liver international : official journal of the International Association for the Study of the Liver
  • The distribution of Hepatitis B virus exposure and infection in a population-based sample of US Hispanic adults Jung, M.; Kuniholm, M. H.; Ho, G. Y.; Cotler, S.; Strickler, H. D.; Thyagarajan, B.; Youngblood, M.; Kaplan, R. C.; Del Amo, J., Hepatology (Baltimore, Md.)
  • Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C Layden, J. E.; Tayo, B. O.; Cotler, S. J.; Clark, N. M.; Baraoidan, K.; Friedman, S. L.; Cooper, R. S., Transplantation
  • Biomechanics and functionality of hepatocytes in liver cirrhosis. Sun, S; Song, Z; Cotler, SJ; Cho, M, Journal of Biomechanics
  • Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients. Gaba, RC; Kallwitz, ER; Parvinian, A; Bui, JT; Von Roenn, NM; Berkes, JL; Cotler, SJ, Annals of hepatology
  • Individualized treatment for patients with low HCV load (genotype 1): a viral kinetic approach Dahari, H.; Cotler, S. J., Hepatology (Baltimore, Md.)
  • Presurgical transarterial chemoembolization does not increase biliary stricture incidence in orthotopic liver transplant patients Casadaban, L.; Malespin, M.; Cheung, A.; McGuffey, R. A.; Boulay, B. R.; Halline, A. G.; Brown, R. D.; Cotler, S. J.; Jeon, H.; Bui, J. T.; Gaba, R. C., Transplantation proceedings
  • Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007-2010 and HCHS/SOL studies. Kuniholm, MH; Jung, M; Everhart, JE; Cotler, S; Heiss, G; McQuillan, G; Kim, RS; Strickler, HD; Thyagarajan, B; Youngblood, M; Kaplan, RC; Ho, GY, The Journal of infectious diseases
  • Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling Guedj, J.; Rotman, Y.; Cotler, S. J.; Koh, C.; Schmid, P.; Albrecht, J.; Haynes-Williams, V.; Liang, T. J.; Hoofnagle, J. H.; Heller, T.; Dahari, H., Hepatology (Baltimore, Md.)
  • Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life Guedj, J.; Dahari, H.; Rong, L.; Sansone, N. D.; Nettles, R. E.; Cotler, S. J.; Layden, T. J.; Uprichard, S. L.; Perelson, A. S., Proceedings of the National Academy of Sciences of the United States of America
  • Phase 1 study of N(1) N(11)-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma., Goyal, L; Supko, JG; Berlin, J; Blaszkowsky, LS; Carpenter, A; Heuman, DM; Hilderbrand, SL; Stuart, KE; Cotler, S; Senzer, NN; Chan, E; Berg, CL; Clark, JW; Hezel, AF; Ryan, DP; Zhu, AX, CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • Physical activity and metabolic syndrome in liver transplant recipients Kallwitz, E. R.; Loy, V.; Mettu, P.; Von Roenn, N.; Berkes, J.; Cotler, S. J., Liver Transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation Gaba, R. C.; Couture, P. M.; Bui, J. T.; Knuttinen, M. G.; Walzer, N. M.; Kallwitz, E. R.; Berkes, J. L.; Cotler, S. J., Journal of vascular and interventional radiology : JVIR
  • Quantitative morphometric analysis of hepatocellular carcinoma: development of a programmed algorithm and preliminary application Yap, F. Y.; Bui, J. T.; Knuttinen, M. G.; Walzer, N. M.; Cotler, S. J.; Owens, C. A.; Berkes, J. L.; Gaba, R. C., Diagnostic and interventional radiology (Ankara, Turkey)
  • Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling Dahari, H.; Cotler, S. J.; Layden, T. J.; Perelson, A. S., Journal of Hepatology
  • Barriers to treatment of hepatitis B in an urban Chinatown community Malespin, M.; Wong, S.; Siqueira, F.; Luc, B.; Ravaee, B.; Vainder, C.; Cotler, S. J., Journal of clinical gastroenterology
  • Characterizing hepatitis B stigma in Chinese immigrants Cotler, S. J.; Cotler, S.; Xie, H.; Luc, B. J.; Layden, T. J.; Wong, S. S., Journal of viral hepatitis
  • Characterizing hepatitis B stigma in Chinese immigrants Cotler, S. J.; Cotler, S.; Xie, H.; Luc, B. J.; Layden, T. J.; Wong, S. S., Journal of viral hepatitis
  • Impact of donor and recipient race on survival after hepatitis C-related liver transplantation Layden, J. E.; Cotler, S. J.; Grim, S. A.; Fischer, M. J.; Lucey, M. R.; Clark, N. M., Transplantation
  • Racial differences in fibrosis progression after HCV-related liver transplantation Layden, J. E.; Cotler, S.; Brown, K. A.; Lucey, M. R.; Te, H. S.; Eswaran, S.; Fimmel, C.; Layden, T. J.; Clark, N. M., Transplantation
  • TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period Gaba, R. C.; Omene, B. O.; Podczerwinski, E. S.; Knuttinen, M. G.; Cotler, S. J.; Kallwitz, E. R.; Berkes, J. L.; Walzer, N. M.; Bui, J. T.; Owens, C. A., Journal of vascular and interventional radiology : JVIR
  • Potential treatment options and future research to increase hepatitis C virus treatment response rate Tencate, V.; Sainz, B., Jr; Cotler, S. J.; Uprichard, S. L., Hepatic medicine : evidence and research
  • Laboratory diagnosis and nonoperative management of biliary complications in living donor liver transplant patients Venu, M.; Brown, R. D.; Lepe, R.; Berkes, J.; Cotler, S. J.; Benedetti, E.; Testa, G.; Venu, R. P., Journal of clinical gastroenterology
  • Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy. Bogetti, D.; Jarzembowski, T. M.; Sankary, H. N.; Manzelli, A.; Knight, P. S.; Chejfec, G.; Cotler, S.; Oberholzer, J.; Testa, G.; Benedetti, E., Transplantation proceedings
  • Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Bogetti, D.; Sankary, H. N.; Jarzembowski, T. M.; Manzelli, A.; Knight, P. S.; Thielke, J.; Chejfec, G.; Cotler, S.; Oberholzer, J.; Testa, G.; Benedetti, E., Clinical transplantation